- AdventHealth
More patients have been helped by an innovative device for stroke survivors at AdventHealth than any other health system in the country. AdventHealth Orlando is the first hospital to use the Vivistim® Paired VNS™ System to help 50 patients. This transformative device, designed to aid stroke survivors in their rehabilitation journey, has shown remarkable success in improving hand and arm function.
Jessica Pflanz was celebrating her 30th birthday when she had a stroke. She’s the 25th patient to receive the Vivistim implant at AdventHealth Orlando and said it is helping her grow more confident and has even allowed her to return to kayaking and paddleboarding.
“I was always very athletic,” Pflanz said. “Thanks to this treatment, I’ve gotten a lot of my movement back. I celebrated the wins and every time I was able to do something I couldn’t do before (using Vivistim).”
The Vivistim System uses vagus nerve stimulation (VNS) paired with high repetition and intense occupational therapy provided at AdventHealth Sports Medicine and Rehab to enhance the treatment’s effectiveness.
The device is implanted under the skin in the upper left chest area and connects to the vagus nerve, which plays a crucial role in controlling involuntary body functions. During rehabilitation therapy, a wireless transmitter signals the Vivistim device to deliver gentle pulses while the patient performs specific tasks, helping to create or strengthen neural connections.
“It gives someone who’s had a stroke a second chance at a good quality of life – something that’s very important in medicine,” said Dr. Ravi H. Gandhi, medical director of the AdventHealth Neuroscience Institute and partner at Orlando Neurosurgery, who led the team in being the first to bring this breakthrough device to stroke survivors in the Southeast. “Vivistim focuses on allowing patients to regain their functional independence.”
Once patients have graduated from the intensive program with the occupational therapists at AdventHealth, they are then able to continue their progress through a self-directed, home-based therapy program using a magnet to activate the Vivistim system daily. This leading-edge medical technology can offer patients the chance to improve their recovery even after significant time has passed.
Recent News
AdventHealth Telesurgery Milestone Earns International Recognition at ERUS26
A team of AdventHealth urologists was recognized at ERUS26 for its work helping establish pathways for transcontinental telesurgery.
Antibiotic Prophylaxis for Peroral Cholangioscopy: Systematic Review Examines Postprocedural Cholangitis Risk
A new study from AdventHealth physicians published in Gastrointestinal Endoscopy examines the use of antibiotic prophylaxis before peroral cholangioscopy.
A Decade of Robotic Liver Resection: Study Highlights Perioperative and Survival Outcomes
A new study from AdventHealth examines a decade of experience using robotic liver resection to treat primary and metastatic hepatobiliary cancers.
AdventHealth Researcher Selected as NIH Rising Star for His Work on How Exercise Transforms Human Adipose Tissue
AdventHealth Translational Research Institute (TRI) researcher Dr. Cheehoon Ahn explores potential benefits of exercise within adipose (fat) tissue.
Improving Care of Patients with Down Syndrome: The Clinical Impact of an Integrated Lifespan Model
What happens when care for pediatric and adult patients with Down syndrome is connected in one place?
Living Donor Liver Transplant Program Expands Access for Pediatric and Complex Liver Disease Patients
AdventHealth has launched a Living Donor Liver Transplant program, expanding access to life-saving transplants for both pediatric and adult patients.
AdventHealth's Lymphatic Network of Excellence Built on Elevated Standards Across Care Teams
Adventhealth is the only center in the Southeast designated a Comprehensive Network of Excellence by the Lymphatic Education & Research Network.
AdventHealth Participating in INNOVATE Clinical Trial to Evaluate BrioVAD System for Heart Failure
AdventHealth is participating in the INNOVATE trial, a Phase 3, multi-center study comparing the investigational BrioVAD system to the HeartMate 3 LVAD.
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...